BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price 8.14% 30.45% 24.49% 18.70% -4.97% 8.65% -2.66% 0.48% 14.52% 04/07/2010
BIB NAV 8.12% 30.51% 24.65% 18.77% -5.03% 8.69% -2.70% 0.43% 14.52% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 10/16/2025
  • NAV
    $66.28
  • NAV Change
    $-0.42 down caret
  • Market Price
    $66.21
  • Market Price Change
    $-0.46 down caret
  • Trading Volume (M)
    25,592
  • 30-Day Median Bid Ask Spread
    0.25%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 10/16/2025
  • NAV
    $66.28
  • NAV Change
    $-0.42 down caret
  • Market Price
    $66.21
  • Market Price Change
    $-0.46 down caret
  • Trading Volume (M)
    25,592
  • 30-Day Median Bid Ask Spread
    0.25%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2025

Holdings

as of 10/16/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
7.67% -- B 11/20/25 -- $4,981,049.70 5,000,000 --
4.97% VRTX VERTEX PHARMACEUTICALS INC -- $3,230,879.27 7,907 2931034
4.97% GILD GILEAD SCIENCES INC -- $3,225,200.95 27,367 2369174
4.89% AMGN AMGEN INC -- $3,178,774.26 10,746 2023607
3.60% ALNY ALNYLAM PHARMACEUTICALS INC -- $2,336,556.99 4,857 B00FWN1
3.38% REGN REGENERON PHARMACEUTICALS -- $2,196,996.20 3,860 2730190
2.50% AZN ASTRAZENECA PLC-SPONS ADR -- $1,621,942.84 19,348 2989044
1.98% INSM INSMED INC -- $1,288,711.43 7,897 2614487
1.47% ARGX ARGENX SE - ADR -- $957,848.32 1,144 BDVLM39
1.20% BIIB BIOGEN INC -- $779,300.28 5,478 2455965
1.13% UTHR UNITED THERAPEUTICS CORP -- $731,246.10 1,690 2430412
0.98% INCY INCYTE CORP -- $637,013.76 7,296 2471950
0.94% SMMT SUMMIT THERAPEUTICS INC -- $609,733.41 27,753 BMTVQS7
0.90% RPRX ROYALTY PHARMA PLC- CL A -- $586,927.34 16,151 BMVP7Y0
0.88% TEM TEMPUS AI INC -- $573,699.06 6,303 BSLSJJ0
0.85% ILMN ILLUMINA INC -- $550,715.22 5,742 2613990
0.84% MEDP MEDPACE HOLDINGS INC -- $546,749.29 1,049 BDCBC61
0.78% NBIX NEUROCRINE BIOSCIENCES INC -- $509,511.60 3,705 2623911
0.77% SNY SANOFI-ADR -- $501,400.48 10,024 2964557
0.72% ASND ASCENDIS PHARMA A/S - ADR -- $470,579.19 2,273 BV9G6B8
0.68% VTRS VIATRIS INC -- $439,935.80 43,558 BMWS3X9
0.67% ROIV ROIVANT SCIENCES LTD -- $436,527.43 25,513 BMW4NZ9
0.67% IONS IONIS PHARMACEUTICALS INC -- $435,131.85 5,955 BDJ0LS6
0.61% ONC BEONE MEDICINES LTD-ADR -- $399,115.10 1,255 BYYWPW6
0.61% BNTX BIONTECH SE-ADR -- $394,890.64 3,758 BK6H543
0.61% MRNA MODERNA INC -- $394,507.04 14,536 BGSXTS3
0.61% EXEL EXELIXIS INC -- $394,374.18 10,058 2576941
0.61% BBIO BRIDGEBIO PHARMA INC -- $393,079.29 7,143 BK1KWG8
0.58% BMRN BIOMARIN PHARMACEUTICAL INC -- $379,863.30 7,174 2437071
0.57% MDGL MADRIGAL PHARMACEUTICALS INC -- $368,294.29 833 BD59BS7
0.53% RVMD REVOLUTION MEDICINES INC -- $346,965.12 6,984 BL71K91
0.48% GH GUARDANT HEALTH INC -- $314,342.73 4,659 BFXC911
0.47% JAZZ JAZZ PHARMACEUTICALS PLC -- $304,210.50 2,266 B4Q5ZN4
0.45% HALO HALOZYME THERAPEUTICS INC -- $292,265.60 4,370 2975098
0.42% RYTM RHYTHM PHARMACEUTICALS INC -- $275,837.58 2,481 BF2YWG4
0.41% MRUS MERUS NV -- $268,130.88 2,826 BZBY005
0.41% CYTK CYTOKINETICS INC -- $263,551.20 4,470 BBBSBJ5
0.36% RNA AVIDITY BIOSCIENCES INC -- $234,436.68 4,806 BMWHPY1
0.36% AXSM AXSOME THERAPEUTICS INC -- $233,000.00 1,864 BYZR4X4
0.36% CRSP CRISPR THERAPEUTICS AG -- $232,525.14 3,398 BDHF4K6
0.35% NUVL NUVALENT INC-A -- $225,236.22 2,491 BMVBZD3
0.33% PCVX VAXCYTE INC -- $211,411.50 4,850 BKPVGH6
0.31% KRYS KRYSTAL BIOTECH INC -- $203,773.06 1,082 BD6JX35
0.31% ARWR ARROWHEAD PHARMACEUTICALS IN -- $201,280.05 5,165 BYQBFJ8
0.31% PTCT PTC THERAPEUTICS INC -- $198,321.76 2,968 B17VCN9
0.29% ALKS ALKERMES PLC -- $189,974.40 6,168 B3P6D26
0.28% ACLX ARCELLX INC -- $184,097.20 2,072 BPCJ1Q2
0.27% PTGX PROTAGONIST THERAPEUTICS INC -- $175,996.52 2,324 BDCBCD8
0.25% KYMR KYMERA THERAPEUTICS INC -- $161,488.66 2,671 BMPRZV5
0.25% AKRO AKERO THERAPEUTICS INC -- $160,336.08 2,988 BK7Y2V9
0.24% -- NEWAMSTERDAM PHARMA CO NV -- $153,465.76 4,208 BP8JSP4
0.23% CRNX CRINETICS PHARMACEUTICALS IN -- $149,058.13 3,523 BDD19F8
0.22% MIRM MIRUM PHARMACEUTICALS INC -- $139,686.34 1,877 BJDX8Y8
0.20% LGND LIGAND PHARMACEUTICALS -- $132,323.64 732 2501578
0.20% ACAD ACADIA PHARMACEUTICALS INC -- $129,988.48 6,304 2713317
0.20% ADMA ADMA BIOLOGICS INC -- $129,802.40 8,915 B9NSBM2
0.20% PRAX PRAXIS PRECISION MEDICINES I -- $127,890.06 786 BQ721R4
0.19% QURE UNIQURE NV -- $122,979.50 2,050 BJFSR88
0.19% RARE ULTRAGENYX PHARMACEUTICAL IN -- $122,325.97 3,601 BJ62Z18
0.19% XENE XENON PHARMACEUTICALS INC -- $121,491.77 2,881 BRJ3GY4
0.18% CGON CG ONCOLOGY INC -- $119,230.65 2,849 BRBCSP4
0.18% TARS TARSUS PHARMACEUTICALS INC -- $118,227.69 1,577 BMH5RL1
0.18% GRAL GRAIL INC -- $116,394.27 1,347 BSLSSX7
0.18% AMRX AMNEAL PHARMACEUTICALS INC -- $115,814.58 11,734 BFNF1D6
0.18% INDV INDIVIOR PLC -- $115,080.09 4,661 BP0BQQ5
0.18% APLS APELLIS PHARMACEUTICALS INC -- $113,939.70 4,718 BYTQ6X1
0.17% IMVT IMMUNOVANT INC -- $113,391.33 6,513 BJRFSB7
0.16% MLYS MINERALYS THERAPEUTICS INC -- $106,393.72 2,476 BP9N0G0
0.16% SRRK SCHOLAR ROCK HOLDING CORP -- $105,748.48 3,592 BFZQ0L8
0.16% VCYT VERACYTE INC -- $105,281.40 2,940 BFTWZY0
0.16% SUPN SUPERNUS PHARMACEUTICALS INC -- $104,197.44 2,094 B72ZBG4
0.16% ALVO ALVOTECH SA -- $102,322.50 11,694 BPNTJ34
0.16% LEGN LEGEND BIOTECH CORP-ADR -- $101,804.56 3,146 BMX9K07
0.16% RXRX RECURSION PHARMACEUTICALS-A -- $101,531.04 15,964 BM9FJ13
0.15% NTLA INTELLIA THERAPEUTICS INC -- $99,889.10 4,010 BYZM6C2
0.15% ADPT ADAPTIVE BIOTECHNOLOGIES -- $98,249.03 5,689 BJ5FZ74
0.15% BEAM BEAM THERAPEUTICS INC -- $97,486.20 3,780 BK6L288
0.15% IRON DISC MEDICINE INC -- $96,593.64 1,299 BMGJZJ8
0.14% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $93,655.89 4,479 BKX9VD3
0.14% FOLD AMICUS THERAPEUTICS INC -- $93,394.76 11,516 B19FQ48
0.14% APGE APOGEE THERAPEUTICS INC -- $92,008.20 1,723 BM9HHL5
0.14% TVTX TRAVERE THERAPEUTICS INC -- $91,635.81 3,331 BLFGJD5
0.14% DNLI DENALI THERAPEUTICS INC -- $91,341.36 5,463 BD2B4V0
0.14% IDYA IDEAYA BIOSCIENCES INC -- $90,684.75 3,275 BK0VHF6
0.14% AGIO AGIOS PHARMACEUTICALS INC -- $90,139.92 2,171 BCBVTX1
0.14% IBRX IMMUNITYBIO INC -- $89,346.95 35,315 BNSP0B8
0.13% DYN DYNE THERAPEUTICS INC -- $87,272.30 5,315 BN15WD1
0.13% COGT COGENT BIOSCIENCES INC -- $85,382.84 5,219 BLR6XK8
0.13% SRPT SAREPTA THERAPEUTICS INC -- $85,214.34 3,651 B8DPDT7
0.13% CNTA CENTESSA PHARMACEUTICALS-ADR -- $81,953.10 3,585 BLB0YQ9
0.13% ETNB 89BIO INC -- $81,840.57 5,541 BK1K484
0.12% OCUL OCULAR THERAPEUTIX INC -- $79,312.20 6,501 BNZB1X8
0.11% ANIP ANI PHARMACEUTICALS INC -- $74,571.45 811 BCDWBX6
0.11% VERA VERA THERAPEUTICS INC -- $72,766.35 2,385 BL55460
0.11% STOK STOKE THERAPEUTICS INC -- $69,980.16 2,048 BJQ05Z6
0.11% TWST TWIST BIOSCIENCE CORP -- $69,341.25 2,255 BGKG6G7
0.10% VCEL VERICEL CORP -- $65,503.75 1,885 BSBMN89
0.10% ABCL ABCELLERA BIOLOGICS INC -- $65,203.60 11,165 BL53SR3
0.10% KNSA KINIKSA PHARMACEUTICALS INTE -- $63,206.08 1,624 BRXB0C0
0.09% GPCR STRUCTURE THERAPEUTICS INC -- $61,348.56 2,226 BQS9486
0.09% MNKD MANNKIND CORP -- $61,332.40 11,464 BF081J4
0.09% JANX JANUX THERAPEUTICS INC -- $61,064.00 2,245 BMFX8Y7
0.09% EWTX EDGEWISE THERAPEUTICS INC -- $60,437.40 3,945 BKY5JZ8
0.09% NVCR NOVOCURE LTD -- $58,603.31 4,177 BYSS4X4
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $56,802.90 4,918 BFWLC09
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $55,766.55 2,149 BKSGZN7
0.08% XERS XERIS BIOPHARMA HOLDINGS INC -- $55,141.62 6,033 BLR7H87
0.08% AVDL AVADEL PHARMACEUTICALS -- $54,405.00 3,627 BDGMC59
0.08% TXG 10X GENOMICS INC-CLASS A -- $52,912.12 4,274 BKS3RS7
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $52,704.96 7,843 2100362
0.08% HROW HARROW INC -- $52,405.44 1,382 BHNDW86
0.08% ZYME ZYMEWORKS INC -- $52,106.95 2,809 BPCQZY9
0.08% TSHA TAYSHA GENE THERAPIES INC -- $51,775.36 10,192 BNC1BX1
0.08% ZLAB ZAI LAB LTD-ADR -- $51,537.08 1,787 BD9GVY0
0.08% NVAX NOVAVAX INC -- $51,456.64 6,068 BJDQXG4
0.08% GMAB GENMAB A/S -SP ADR -- $51,286.50 1,566 BBC9WC7
0.08% SANA SANA BIOTECHNOLOGY INC -- $51,278.13 9,666 BMFJJ97
0.08% AMLX AMYLYX PHARMACEUTICALS INC -- $50,546.44 3,332 BPCK358
0.08% SYRE SPYRE THERAPEUTICS INC -- $50,195.68 2,257 BQBBDY8
0.08% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $50,160.88 1,496 BLCD809
0.07% SNDX SYNDAX PHARMACEUTICALS INC -- $48,430.90 3,218 BN7Q7R7
0.07% TRVI TREVI THERAPEUTICS INC -- $48,366.50 4,550 BJH9ZN0
0.07% ORIC ORIC PHARMACEUTICALS INC -- $48,252.40 3,628 BKVDFF7
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $48,132.75 2,213 BMFD115
0.07% WVE WAVE LIFE SCIENCES LTD -- $46,787.15 5,945 BYZG9R0
0.07% TRML TOURMALINE BIO INC -- $45,984.00 960 BQ80NC6
0.07% ARDX ARDELYX INC -- $45,470.20 9,004 BN89V40
0.07% CVAC CUREVAC NV -- $45,172.44 8,412 BN4RD42
0.07% GRFS GRIFOLS SA-ADR -- $44,440.50 4,558 B8K7T65
0.07% LENZ LENZ THERAPEUTICS INC -- $43,119.70 1,066 BQV0J03
0.07% DVAX DYNAVAX TECHNOLOGIES CORP -- $42,933.80 4,381 BRJZSK0
0.06% RLAY RELAY THERAPEUTICS INC -- $41,937.42 6,442 BN2R582
0.06% INVA INNOVIVA INC -- $40,606.50 2,354 BDDXF67
0.06% AMPH AMPHASTAR PHARMACEUTICALS IN -- $40,333.14 1,737 BNFWZS4
0.06% XNCR XENCOR INC -- $39,826.80 2,664 BGCYWN8
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $39,088.17 1,177 BX7RSN3
0.06% PGEN PRECIGEN INC -- $38,854.17 11,133 BKM5C84
0.06% PCRX PACIRA BIOSCIENCES INC -- $38,230.83 1,679 B3X26D8
0.06% TNGX TANGO THERAPEUTICS INC -- $38,110.52 4,156 BP2P6L0
0.06% PRME PRIME MEDICINE INC -- $37,891.40 6,533 BPBJFM7
0.06% SPRY ARS PHARMACEUTICALS INC -- $37,326.12 3,692 BMCR7V2
0.06% ORKA ORUKA THERAPEUTICS INC -- $37,184.00 1,400 BKVF0J2
0.06% ANAB ANAPTYSBIO INC -- $35,982.40 1,046 BDRW1L7
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $35,271.50 2,650 BJLKVS6
0.05% PSNL PERSONALIS INC -- $34,057.64 3,313 BJQ0608
0.05% RAPP RAPPORT THERAPEUTICS INC -- $33,897.81 1,363 BR3T9B6
0.05% MNMD MIND MEDICINE MINDMED INC -- $33,860.13 2,843 BPQYY97
0.05% KURA KURA ONCOLOGY INC -- $32,851.59 3,243 BYZD465
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $32,300.62 7,162 BZ0QMB7
0.05% FTRE FORTREA HOLDINGS INC -- $32,263.28 3,389 BRXYZ57
0.05% MESO MESOBLAST LTD- SPON ADR -- $31,910.76 1,764 BQS7491
0.05% AQST AQUESTIVE THERAPEUTICS INC -- $31,685.20 4,520 BYVQJ96
0.05% IOVA IOVANCE BIOTHERAPEUTICS INC -- $30,284.80 13,520 BF0DMK7
0.05% VIR VIR BIOTECHNOLOGY INC -- $30,102.00 5,190 BK4PZ38
0.05% EYPT EYEPOINT PHARMACEUTICALS INC -- $29,741.25 2,575 BMGS7L1
0.05% AVBP ARRIVENT BIOPHARMA INC -- $29,731.88 1,515 BMGTLY5
0.05% TYRA TYRA BIOSCIENCES INC -- $29,546.44 1,991 BMVNDH9
0.05% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $29,351.77 761 BL95N25
0.05% GERN GERON CORP -- $29,318.28 23,836 2370381
0.05% URGN UROGEN PHARMA LTD -- $29,271.97 1,729 BZ7PJQ1
0.04% AVXL ANAVEX LIFE SCIENCES CORP -- $28,913.09 3,209 BYTYP72
0.04% NRIX NURIX THERAPEUTICS INC -- $28,645.68 2,856 BMVLGP2
0.04% DAWN DAY ONE BIOPHARMACEUTICALS I -- $28,587.69 3,827 BLB0YH0
0.04% TERN TERNS PHARMACEUTICALS INC -- $28,154.70 3,270 BMDJ0C9
0.04% CRMD CORMEDIX INC -- $28,113.12 2,789 BJ0LT31
0.04% ABSI ABSCI CORP -- $27,208.69 5,587 BN94K69
0.04% ERAS ERASCA INC -- $26,812.94 10,598 BNLYBF3
0.04% ARVN ARVINAS INC -- $26,552.24 2,743 BDZ30Q0
0.04% TBPH THERAVANCE BIOPHARMA INC -- $26,409.24 1,881 BMNDK09
0.04% ATXS ASTRIA THERAPEUTICS INC -- $25,497.81 2,109 BMYRFN8
0.04% OMER OMEROS CORP -- $24,987.86 2,542 B4NB858
0.04% OLMA OLEMA PHARMACEUTICALS INC -- $24,614.40 2,564 BMZ4LN0
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $24,438.78 3,006 BFYQFJ2
0.04% CSTL CASTLE BIOSCIENCES INC -- $24,422.52 1,084 BKLCWZ3
0.04% ZVRA ZEVRA THERAPEUTICS INC -- $23,875.24 2,098 BLFBZ32
0.04% GLUE MONTE ROSA THERAPEUTICS INC -- $23,795.48 2,308 BP7KZP7
0.04% RGNX REGENXBIO INC -- $23,285.58 1,887 BZ0G875
0.04% SVRA SAVARA INC -- $23,116.06 6,457 BYXGN81
0.03% SIGA SIGA TECHNOLOGIES INC -- $22,344.60 2,676 2107437
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $22,055.95 1,015 BKC9SX3
0.03% CMPS COMPASS PATHWAYS PLC -- $21,960.66 3,426 BMC3HS7
0.03% CRVS CORVUS PHARMACEUTICALS INC -- $21,297.60 2,784 BYP80F1
0.03% KROS KEROS THERAPEUTICS INC -- $20,857.32 1,518 BM7V485
0.03% KALV KALVISTA PHARMACEUTICALS INC -- $20,766.24 1,881 BD06CS0
0.03% PRTA PROTHENA CORP PLC -- $20,290.99 2,011 B91XRN2
0.03% ESPR ESPERION THERAPEUTICS INC -- $19,962.45 7,533 BBNBTD2
0.03% LXRX LEXICON PHARMACEUTICALS INC -- $19,956.72 13,576 BWFZX59
0.03% INBX INHIBRX BIOSCIENCES INC -- $19,797.90 541 BNSP8K3
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $19,750.72 11,222 B4N8MH9
0.03% CGEM CULLINAN THERAPEUTICS INC -- $19,289.18 2,207 BM90J52
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $18,866.94 5,406 BMCWKZ2
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $18,833.70 670 BQD3J33
0.03% GLPG GALAPAGOS NV-SPON ADR -- $18,238.15 535 B292NQ7
0.03% NGNE NEUROGENE INC -- $18,116.67 533 BS2F741
0.03% SLDB SOLID BIOSCIENCES INC -- $17,919.44 2,909 BQHN6C7
0.03% HCM HUTCHMED CHINA-ADR -- $17,848.60 1,159 BYXV9H7
0.03% LXEO LEXEO THERAPEUTICS INC -- $17,689.09 2,017 BQ6C357
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $17,607.05 1,745 BKLXFX5
0.03% ALMS ALUMIS INC -- $16,683.59 3,619 BPLQG36
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $16,124.00 4,031 BDFKQ07
0.02% EOLS EVOLUS INC -- $15,220.80 2,416 BDRJH21
0.02% AMRN AMARIN CORP PLC -ADR -- $15,112.71 753 BN72KB0
0.02% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $14,938.55 1,727 BKDQKM6
0.02% AURA AURA BIOSCIENCES INC -- $14,366.99 2,321 BP81R42
0.02% LRMR LARIMAR THERAPEUTICS INC -- $13,623.48 3,198 BMXNGZ6
0.02% REPL REPLIMUNE GROUP INC -- $13,617.72 2,916 BDDVW37
0.02% EDIT EDITAS MEDICINE INC -- $13,301.64 3,359 BZ8FPH3
0.02% DSGN DESIGN THERAPEUTICS INC -- $13,129.76 2,128 BMFK3H6
0.02% ANNX ANNEXON INC -- $13,016.02 4,106 BMVV9R5
0.02% ALT ALTIMMUNE INC -- $12,825.33 3,297 BFY7DC4
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $12,588.24 7,493 BFMLGR4
0.02% TECX TECTONIC THERAPEUTIC INC -- $12,337.35 699 BPBPCG8
0.02% LYEL LYELL IMMUNOPHARMA INC -- $12,206.00 718 BTNMG41
0.02% ALEC ALECTOR INC -- $12,178.04 3,782 BJ4LDC4
0.02% VNDA VANDA PHARMACEUTICALS INC -- $11,630.89 2,207 B12W3P6
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $11,558.86 1,754 BL5B6Z1
0.02% KYTX KYVERNA THERAPEUTICS INC -- $11,328.16 1,616 BSMLR16
0.02% ACIU AC IMMUNE SA -- $11,102.96 3,751 BZC0D70
0.02% VYGR VOYAGER THERAPEUTICS INC -- $11,043.76 2,072 BY7RB53
0.02% NMRA NEUMORA THERAPEUTICS INC -- $10,770.78 6,051 BN4JN37
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $10,527.03 8,289 BFZNYB7
0.02% TKNO ALPHA TEKNOVA INC -- $10,514.74 1,999 BP7L561
0.02% HUMA HUMACYTE INC -- $10,058.90 5,917 BMYTJP4
0.01% IRWD IRONWOOD PHARMACEUTICALS INC -- $9,406.95 6,069 B3MZ6K5
0.01% AVIR ATEA PHARMACEUTICALS INC -- $9,250.80 2,965 BLN9Z50
0.01% RNAC CARTESIAN THERAPEUTICS INC -- $9,146.82 971 BQB9HM8
0.01% FHTX FOGHORN THERAPEUTICS INC -- $9,102.72 2,112 BMF7DT9
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $9,081.24 798 B9L5200
0.01% CDXS CODEXIS INC -- $8,902.08 3,372 B5LL2C2
0.01% TRDA ENTRADA THERAPEUTICS INC -- $8,781.78 1,421 BP81RK8
0.01% OABI OMNIAB INC -- $7,792.80 4,584 BN13S71
0.01% PYXS PYXIS ONCOLOGY INC -- $7,761.95 2,317 BLBR8D5
0.01% MXCT MAXCYTE INC -- $7,049.91 3,983 BKMQF66
0.01% APLT APPLIED THERAPEUTICS INC -- $6,725.00 5,380 BJL38Z1
0.01% FATE FATE THERAPEUTICS INC -- $6,635.86 4,309 BCZS820
0.01% NKTX NKARTA INC -- $6,605.97 2,653 BK80YJ8
0.01% CCCC C4 THERAPEUTICS INC -- $6,594.32 2,659 BKX9NQ0
0.01% PEPG PEPGEN INC -- $5,880.00 1,225 BMTX3D7
0.01% TVGN TEVOGEN BIO HOLDINGS INC -- $5,304.51 7,349 BPG5P75
0.01% CLYM CLIMB BIO INC -- $4,935.45 2,531 BMW5LX6
0.01% TCRX TSCAN THERAPEUTICS INC -- $4,860.80 1,960 BNLYBJ7
0.01% MGNX MACROGENICS INC -- $3,991.78 2,362 BFDV8K0
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,785.10 2,294 BMDWW66
0.01% BMEA BIOMEA FUSION INC -- $3,534.57 2,223 BNKF6N0
-- STRO SUTRO BIOPHARMA INC -- $2,789.18 3,167 BF12XC2
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $2,526.24 912 BMF1LJ7
-- ACRV ACRIVON THERAPEUTICS INC -- $2,197.25 1,175 BP2TPK4
-- MRSN MERSANA THERAPEUTICS INC -- $1,970.05 187 BVPKH99
-- QTTB Q32 BIO INC -- $1,641.60 456 BS2FKQ4
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,379.52 479 BT7KGT6
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
29.18% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 18,956,753 -- 3,675 --
26.77% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 17,388,629 -- 3,371 --
23.56% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 15,304,676 -- 2,967 --
20.26% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 13,158,823 -- 2,551 --
19.73% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 12,813,217 -- 2,484 --
15.24% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 9,898,778 -- 1,919 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $17,766,544.28 17,766,544 --

Index

as of 9/30/2025

  • Total Number of Companies251
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.56 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.